Head-to-head · Cost-Efficiency Index
Kina vs WeightRx
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Kina
Cost-first shoppers who want perimenopausal/menopausal women wanting GLP-1 weight management bundled with HRT and other menopause-specific care under one named clinical lead.
Visit KinaWeightRx
Cost-first shoppers who want the lowest published tirzepatide figure, if you are willing to complete intake before you can read the plan terms.
Visit WeightRxThe verdict
Kina and WeightRx tie on the Cost-Efficiency Index at 69/100, so neither wins outright on the numbers. For most shoppers we'd start with Kina (ranked #103, a hair above #109) — Cost-first shoppers who want perimenopausal/menopausal women wanting GLP-1 weight management bundled with HRT and other menopause-specific care under one named clinical lead. But WeightRx is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Kina.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Kina | WeightRx |
|---|---|---|
| Cost-Efficiency Index | 69/100 | 69/100 |
| Semaglutide / mo | $169/mo (all doses, compounded) | $250/mo (compounded) |
| Tirzepatide / mo | $249/mo (compounded) | $83/mo (term not published, compounded) |
| Semaglutide / yr (modeled) | $2,028 | $3,000 |
| Tirzepatide / yr (modeled) | $2,988 | $996 |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #103 | #109 |
Kina
69/100Where the value is
- Names an actual clinical lead (Dr. Shannon Arora, PharmD) tied to a real affiliated practice with an address
- LegitScript badge confirmed with verification link
- Consultation/physician-review fee is bundled into the price rather than charged separately
The tradeoffs
- $169 headline price is a first-month-only discount; true ongoing price is $199/mo
- Not a dedicated GLP-1 company -- weight/GLP-1 is one of six categories on a menopause-focused platform
WeightRx
69/100Where the value is
- The tirzepatide figure is published up front, and it is genuinely low against the field
- Both molecules are offered
- No membership charge is advertised alongside the medication rate
The tradeoffs
- The $83 monthly rate is advertised as '$83/month ($997/year)', which is twelve months of it — no month-to-month rate is separately published, and the terms state that a rate is locked for its full term
- Both product pages linked from the homepage return 404, so the plan terms cannot be read before intake
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.